CIK 0001841387
- Emerging growth company
Candel Therapeutics, Inc.
Sign in to watch- Ticker
- CADL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 522214851
- Phone
- +1 617-916-5445
- Business address
- 117 KENDRICK STREET, SUITE 450, NEEDHAM, MA, 02494
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,160,783
- in 1 filing, $3.2M under 10b5-1 plans
Net −$3,160,783. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-30 | PAPA JOSEPH C Director | Grant or award · Stock Option (Right to Buy) | +1,325 | $8.68 | $11K | 1,325 |
| 2026-06-30 | PAPA JOSEPH C Director | Grant or award · Stock Option (Right to Buy) | +1,331 | $8.64 | $11K | 1,331 |
| 2026-06-23 | PAPA JOSEPH C Director | Grant or award · Stock Option (Right to Buy) | +32,000 | 32,000 | ||
| 2026-03-31 | PAPA JOSEPH C Director | Grant or award · Stock Option (Right to Buy) | +2,795 | $4.11 | $11K | 2,795 |
| 2025-06-25 | PAPA JOSEPH C Director | Grant or award | +64,239 | $4.67 | $300K | 64,239 |
| 2025-06-17 | PAPA JOSEPH C Director | Grant or award · Stock Option (Right to Buy) | +14,240 | 14,240 | ||
| 2024-06-26 | PAPA JOSEPH C Director | Grant or award · Stock Option (Right to Buy) | +14,240 | 14,240 | ||
| 2023-06-28 | PAPA JOSEPH C Director | Grant or award · Stock Option (Right to Buy) | +14,240 | 14,240 | ||
| 2022-12-09 | PAPA JOSEPH C Director | Purchase | +35,018 | $1.94 | $68K | 38,032 |
| 2022-12-08 | PAPA JOSEPH C Director | Purchase | +3,014 | $1.70 | $5K | 3,014 |
| 2022-08-08 | PAPA JOSEPH C Director | Grant or award · Stock Option (Right to Buy) | +28,480 | 28,480 |
Page 1 of 1 · 11 trades